Answer
Glofitamab (Columvi) monotherapy is indicated for adults with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked